Charles Schwab Investment Management Inc Imago Bio Sciences, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $22,049 - $52,753	1,467 Added 2.14%	69,966 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $101,653 - $140,088	7,184 Added 11.72%	68,499 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $154,297 - $273,319	13,065 Added 27.08%	61,315 $822,000
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $391,362 - $576,550	23,062 Added 91.56%	48,250 $930,000
Q4 2021 Feb 11, 2022	BUY	$16.22 - $29.69 $22,967 - $42,041	1,416 Added 5.96%	25,188 $598,000
Q3 2021 Nov 16, 2021	BUY	$16.0 - $28.84 $380,352 - $685,584	23,772 New	23,772 $477,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.